POLICYBZR Q4 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹2,061 Cr
verified against source
Revenue YoY
37%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
PB Fintech delivered another exceptional quarter with new insurance premium growth of 67% YoY in Q4 FY26, driven by strong momentum in health (+68% for FY26) and term insurance. Total premium crossed INR 29,934 crore while operating revenue reached INR 6,794 crore (FY26) and INR 2,000 crore in Q4. The company's renewal revenue ARR stands at INR 1,126 crore (63% YoY growth), demonstrating strong profitability visibility. Paisabazaar achieved EBITDA breakeven this quarter with improving CSAT to 90%. Management remains focused on growth and quality over near-term margins, with guidance of ~30% growth they expect to beat easily in FY27. Key risks include potential commission regulation changes (though no formal regulator communication), sustainability of 60%+ health growth, and capital allocation decisions. The company's claims experience differentiation (only 5% of customers file multiple claims) and sub-80% loss ratios position it as the industry's most profitable book.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects to grow ~30% (their stated steady-state guidance) but confidence that they will beat this significantly. Stated: 'We will beat last year' and 'What we will do is in one year, we will give the growth of what we promised in two years.'
- Management signaled very aggressive expansion plans for POSP business in FY27, citing improved model for smaller cities, competitive landscape consolidation, and opportunity to deepen penetration while quality metrics are at all-time highs.
- Expects to be 'significantly positive' on EBITDA next year with operating leverage as fixed costs stabilize and revenue scales. CSAT improved from 72% to 90%, conversion rates rising with supply partnerships strengthening.
Risks flagged
- Yashish stated media has more visibility than regulators on this topic, though he acknowledged two regulatory conversations (deferred revenues in life, lower EOM in health) that they would 'welcome.'
- Sarbvir deflected when asked for specific guidance on next year, stating focus should be on fundamentals rather than speculating on growth rates. Yashish then gave bullish commentary but without specific numbers.
- Manas asked specifically whether PB Fintech would participate in the next funding round. Yashish gave non-committal response: 'When it comes to the board, yeah, PB Fintech might consider it.' This represents potential cash outflow or strategic uncertainty.
- Sanketh asked for split of INR 6,794 crore revenue between recognized-received vs recognized-receivable. Management deflected saying they could explain 'in a more closed setting,' suggesting this is material information not disclosed publicly.
Key quotes
- Only 5% of customers bought insurance 10 years ago have ever made more than 1 claim. Those 67% do not interact with anybody. That is our job, and that is what Policybazaar really, really specializes at—bringing in that 67% of people who are not gonna claim because without that, please appreciate that 5% of lives will simply not be able to afford their situation.
- If Policybazaar was an insurance company, our total costs and the claims paid out on our book, and when I'm looking at a fully loaded delayed book, are less than 80%. There is no insurance company in the country who can compete with that. All I'm saying is we have the most profitable book in the industry by a 20% delta from the rest of the industry.
- Please read us. While a lot of questions come around profits, that has not been our focus. Our focus is the other two [growth and quality]. This leg [profitability] will just follow along.
Research modules